Cargando…
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
BACKGROUND: Metabolic reprogramming is a hallmark of cancer, alteration of nucleotide metabolism of hepatocellular carcinoma (HCC) is not well-understood. MYBL2 regulates cell cycle progression and hepatocarcinogenesis, its role in metabolic regulation remains elusive. PATIENTS AND METHODS: Copy num...
Autores principales: | Zhao, Jun-Zhang, Wang, Wei, Liu, Tao, Zhang, Lei, Lin, De-Zheng, Yao, Jia-Yin, Peng, Xiang, Jin, Gang, Ma, Tian-Tian, Gao, Jin-Bo, Huang, Fang, Nie, Jun, Lv, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733023/ https://www.ncbi.nlm.nih.gov/pubmed/36494680 http://dx.doi.org/10.1186/s12885-022-10354-4 |
Ejemplares similares
-
Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation
por: O’Neill, Audrey G., et al.
Publicado: (2023) -
The Role of Purine Metabolism-Related Genes PPAT and IMPDH1 in the Carcinogenesis of Intrahepatic Cholangiocarcinoma Based on Metabonomic and Bioinformatic Analyses
por: Liu, Chang-Jun, et al.
Publicado: (2023) -
Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds
por: Souckova, Olga, et al.
Publicado: (2022) -
MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma
por: Zhu, Jinrong, et al.
Publicado: (2022) -
Cytoophidium assembly reflects upregulation of IMPDH activity
por: Chang, Chia-Chun, et al.
Publicado: (2015)